Copertina

Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Isabella Gruber, Oliver Koelbl, Maria M. Meier
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	The Prostate
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Impact of Intraprostatic Simultaneous Integrated Boost on Long‐Term Outcomes in Unfavorable Intermediate‐Risk Prostate Cancer Treated With Dose‐Escalated Radiotherapy and Short‐Term Androgen Deprivation Therapy
di: Cem Onal, et al.
Pubblicazione: (2026)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
di: Erum Z. Whyne, et al.
Pubblicazione: (2025)

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial
di: Braden Millan, et al.
Pubblicazione: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
di: Charly Bâcle, et al.
Pubblicazione: (2025)

Comments on the Study “Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients”
di: Leibo Wang, et al.
Pubblicazione: (2026)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
di: Victor Sandoval, et al.
Pubblicazione: (2025)

LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy
di: Sangjon Pae, et al.
Pubblicazione: (2025)

Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer
di: Cem Onal, et al.
Pubblicazione: (2025)

Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
di: Cem Onal, et al.
Pubblicazione: (2024)

Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients: A Randomized Placebo‐Controlled Trial
di: Vida Nazari, et al.
Pubblicazione: (2025)

A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP‐00)
di: Liam D. King, et al.
Pubblicazione: (2026)

Integration of Primary Care Into the Follow‐Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region
di: Angel Borque‐Fernando, et al.
Pubblicazione: (2025)

Mortality and Additional Treatment Rates in Pathologically High‐Risk Prostate Cancer With Prostate‐Specific Antigen Persistence at Robot‐Assisted Radical Prostatectomy: Long‐Term Report From Single Tertiary Referral Center
di: Alessandro Bertini, et al.
Pubblicazione: (2025)

Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable‐Intermediate and High‐Risk Prostate Cancer
di: Andre Gouveia, et al.
Pubblicazione: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
di: Elizabeth Robinson, et al.
Pubblicazione: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
di: Tatsuya Shimomura, et al.
Pubblicazione: (2026)

Evidence and Rationale for Prostate Cancer Screening
di: Takeshi Takahashi
Pubblicazione: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
di: Sheila Jonnatan, et al.
Pubblicazione: (2026)

Altered Glycosylation of PSA in Prostate Cancer Tissue
di: Hannu Koistinen, et al.
Pubblicazione: (2025)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
di: Andrea K. Miyahira, et al.
Pubblicazione: (2024)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
di: Marta Victoria Lorenzo‐Sánchez, et al.
Pubblicazione: (2025)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
di: Y. M. Yáñez‐Castillo, et al.
Pubblicazione: (2025)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
di: Yifu Shi, et al.
Pubblicazione: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
di: Reid Vassallo, et al.
Pubblicazione: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
di: Haotian Chen, et al.
Pubblicazione: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
di: Trevor C. Hunt, et al.
Pubblicazione: (2025)

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
di: Emily Chan, et al.
Pubblicazione: (2025)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
di: Liza M. Kurucz, et al.
Pubblicazione: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
di: Christian P. Pavlovich, et al.
Pubblicazione: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
di: Kristofer G. Taylor, et al.
Pubblicazione: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
di: Muhammad Umair, et al.
Pubblicazione: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
di: Christian Andrés Martínez Osorio, et al.
Pubblicazione: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
di: Cameron J. Britton, et al.
Pubblicazione: (2025)

Baseline Imaging Derived Factors of Response Following [225Ac]Ac‐J591 Therapy in Metastatic Castration‐Resistant Prostate Cancer: A Lesion Level Analysis
di: Judith Stangl‐Kremser, et al.
Pubblicazione: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
di: Yu‐Hsiang Lin, et al.
Pubblicazione: (2025)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
di: Anwar E. Ahmed, et al.
Pubblicazione: (2025)

Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
di: Anna‐Lena Lemster, et al.
Pubblicazione: (2025)

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
di: Andrea K. Miyahira, et al.
Pubblicazione: (2024)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
di: Hanna Zurl, et al.
Pubblicazione: (2025)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
di: Fabian Falkenbach, et al.
Pubblicazione: (2025)